Public Sector Pension Investment Board Has $2.88 Million Stock Position in Dynavax Technologies Co. (NASDAQ:DVAX)

Public Sector Pension Investment Board lessened its position in Dynavax Technologies Co. (NASDAQ:DVAX) by 10.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 258,558 shares of the biopharmaceutical company’s stock after selling 29,400 shares during the period. Public Sector Pension Investment Board’s holdings in Dynavax Technologies were worth $2,880,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Bank of Montreal Can lifted its holdings in shares of Dynavax Technologies by 8.3% in the 3rd quarter. Bank of Montreal Can now owns 1,077,081 shares of the biopharmaceutical company’s stock worth $11,848,000 after purchasing an additional 82,449 shares in the last quarter. Intech Investment Management LLC bought a new position in shares of Dynavax Technologies in the third quarter valued at $416,000. Quest Partners LLC acquired a new position in shares of Dynavax Technologies during the third quarter valued at about $237,000. Mizuho Markets Americas LLC increased its position in shares of Dynavax Technologies by 17.4% during the third quarter. Mizuho Markets Americas LLC now owns 1,379,582 shares of the biopharmaceutical company’s stock worth $15,369,000 after acquiring an additional 204,475 shares in the last quarter. Finally, Aigen Investment Management LP bought a new position in Dynavax Technologies in the 3rd quarter valued at about $228,000. Institutional investors and hedge funds own 96.96% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have commented on DVAX. HC Wainwright reissued a “buy” rating and set a $29.00 price objective on shares of Dynavax Technologies in a report on Friday, November 8th. The Goldman Sachs Group lowered their price target on Dynavax Technologies from $20.00 to $15.00 and set a “neutral” rating for the company in a research report on Thursday, August 8th.

Dynavax Technologies Price Performance

Dynavax Technologies stock opened at $12.79 on Wednesday. Dynavax Technologies Co. has a 52 week low of $9.74 and a 52 week high of $15.01. The company’s 50 day moving average price is $11.73 and its two-hundred day moving average price is $11.41. The stock has a market cap of $1.68 billion, a P/E ratio of 98.39 and a beta of 1.33. The company has a quick ratio of 12.34, a current ratio of 13.23 and a debt-to-equity ratio of 0.33.

Dynavax Technologies Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.